Futures
Hundreds of contracts settled in USDT or BTC
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Cumberland Partners Ltd Acquires 19,130 Shares of AbbVie Inc. $ABBV
Cumberland Partners Ltd significantly increased its stake in AbbVie Inc. by 76.2% during the third quarter, acquiring an additional 19,130 shares to bring its total holdings to 44,232 shares valued at $10.241 million. This increase comes as AbbVie reported strong Q1 2026 earnings, beating analyst estimates with $2.71 EPS and $16.62 billion in revenue, and received a “Moderate Buy” consensus rating from analysts with a target price of $251.56. Other institutional investors also adjusted their positions in AbbVie, with hedge funds now owning 70.23% of the company’s stock.